Methods and compositions to regulate iron metabolism

Details Methods and compositions to regulate iron metabolism Methods and compositions to regulate iron metabolism

2011-06-28

2011-06-28

Saoud, Christine J (Department: 1647)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Structurally-modified antibody, immunoglobulin, or fragment...

C514S001100, C514S005400, C514S007600, C530S350000

Reexamination Certificate

active

07968091

ABSTRACT:
The present invention provides new systems and strategies for the regulation of iron metabolism in mammals. In particular, methods of using agonists and antagonists of TGF-β superfamily members to modulate the expression or activity of hepcidin, a key regulator of iron metabolism, are described. The inventive methods find applications in the treatment of diseases associated with iron overload, such as juvenile hemochromatosis and adult hemochromatosis, and in the treatment of diseases associated with iron deficiency, such as anemia of chronic disease and EPO resistant anemia in end-stage of renal disease. The present invention also relates to screening tools and methods for the development of novel drugs and therapies for treating iron metabolism disorders.

REFERENCES:
patent: 5571714 (1996-11-01), Dash et al.
patent: 5719120 (1998-02-01), Letarte et al.
patent: 5830847 (1998-11-01), Letarte et al.
patent: 6015693 (2000-01-01), Letarte et al.
patent: 1284380 (2001-02-01), None
patent: WO/94/24314 (1994-10-01), None
patent: WO/95/12608 (1995-11-01), None
patent: WO/02/051438 (2002-07-01), None
patent: WO/02/098444 (2002-12-01), None
patent: WO/02/098444 (2002-12-01), None
patent: WO/03/004615 (2003-01-01), None
patent: WO/03/089608 (2003-10-01), None
patent: WO/03/089608 (2003-10-01), None
patent: 2004/003150 (2004-01-01), None
patent: WO/2004/004750 (2004-01-01), None
patent: WO/2004/004750 (2004-01-01), None
patent: WO/2004/016606 (2004-02-01), None
patent: WO/2005/028517 (2005-03-01), None
patent: WO/2005/028517 (2005-03-01), None
Augsburger et al., Neuron., 24:127-141 (1999).
Babitt, J.L., et al., J. Biol. Chem., 280:29820-29827 (2005).
Babitt, et al., Nat. Genet., 38(5):531-539 (2006).
Balemans et al. Dev. Biol., 250:231-250 (2002).
Brinks et al., J. Neurosci., 24(15) 3862-3869 (2004).
Brown, C.B., et al., Science, 283:2080-2082(1999).
Chappuis-Flament et al., J. Cell Biol., 154(1):231-243 (2001).
Cheng, S.K., et al., Genes Dev., 17:31-36 (2003).
Database TrEMBL Q95XN8, Du, et al., “The sequence ofC. eleganscosmid Y71G12B”, Dec. 2001, 100% identical to SEQ ID No. 18.
Database, Auffray, C., et al., NCBI Accession No. CAB98207, Jul. 2000, 100% identical to SEQ ID No. 10 over 446 residues.
Database, WPI Week 2001 Derwent Publications Ltd., 2001-317422 XP002416009 & CN 1 284 380 A (Inst Hematology Chinese Acad Medical Sci) Feb. 21, 2001.
De Angelis et al., Microbiol., 147:1863-1873 (2001).
del Re, E., et al., J. Biol. Chem., 279:22765-22772 (2004).
Dennler et al., EMBO J., 17:3091-3100 (1998).
Feng et al., Science, 297:392-395 (2002).
Gray et al., Proc. Natl. Acad. Sci. USA, 100(9):5193-5198 (2003).
Groppe et al., Nature, 420:636-642(2002).
Hollnagel et al., J. Biol. Chem., 274(28):19838-19845 (1999).
Hoodless et al., Cell, 85:489-500 (1996).
Hsu, D. et al., Mol. Cell, 1:673-683 (1998).
Keutmann et al., Molec. Encocrinology, 18(1):228-240 (2004).
Klahr, J. Nephrol., 16:179-185 (2003).
Korchynskyi et al., J. Biol. Chem., 277:4883-4891 (2002).
Krijt et al., Blood, 104(13) 4308-4310 (2004).
Lopez-Rovira et al., J. Biol. Chem., 277(5):3176-3185 (2002).
Lopez-Casillas et al., Cell, 73:1435-1444 (1993).
Lu et al., Dev Dyn 222(4):667-680 (2001).
Macias-Silva et al., Cell, 87:1215-1224 (1996).
Martinez et al., Haematologica, 89:1441-1445 (2004).
Massagué et al., Annu. Rev. Biochem., 67:753-791 (1998).
Massagué et al., Genes Dev., 14:627-644 (2000).
Massagué, Nat. Rev. Mol. Cell Biol., 200(1):169-178 (2000).
Matsunaga et al., Nat. Cell Biol., 6:749-755 (2004).
McMahon et al., Genes Dev., 12:1438-1452 (1998).
Monnier et al., Nature, 419:392-395 (2002).
Nemeth et al., Blood, 105(4):1803-1806 (2005).
Niederkofler et al., J. Neurosci., 24(4):808-818 (2004).
Nishi et al., Endocrinology, 142:437-445 (2001).
Oldekamp et al., Gene Expr. Patterns; 4:283-288 (2004).
Onichtchouk et al., Nature, 401:480-485 (1999).
Papanikolaou et al., Nature Genetics, 36:77-82 (2004).
Puglisi et al., Eur. J. Endocrinol., 151:511-520 (2004).
Rajagopalan et al., Nat. Cell Biol., 6:756-762 (2004).
Roetto et al., Nature Genetics, 33(1):21-22 (2003).
Samad et al., J. Neuroscience, 24:2027-2036 (2004).
Samad et al., J. Biol. Chem., 280:14122-14129 (2005).
Schmidtmer et al., Gene Expr. Patterns, 4:105-110 (2004).
Shen et al., Trends Genet., 16:303-309 (2000).
Shi et al., Cell, 113:685-700(2003).
Storm et al., Development, 122:3969-3979 (1996).
Wiater et al., J. Biol. Chem., 278(10):7934-7941 (2003).
Weinstein et al., Blood, 100(10):3776-3781 (2002).
Xia et al., Mol. Endocrinol., 18:979-994 (2004).
Xia et al., Endocrinology 146(8):3614-3621 (2005).
Xia et al., J. Biol. Chem., 282(25):18129-18140 (2007).
Yamaguchi et al., Nature, 346:281-284 (1990).
International Preliminary Report on Patentability, Application No. PCT/US2006/005367, Dated: Aug. 21, 2007.
Examination Report, European Application No. 06735151.0, Dated: Nov. 12, 2008.
European Examination Report, Application No. EP 06735151.0, Mailing Date: Apr. 16, 2010.

Affiliated with

Also associated with

Rating

Methods and compositions to regulate iron metabolism does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions to regulate iron metabolism, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions to regulate iron metabolism will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2686840